Duke Debates: Controversies in the Management of Hematologic Malignancies
April 13, 2018 to April 15, 2018
This annual event brings together experts in the field of Hematologic Malignancies to debate and discuss advances in treatment for these cancers, novel treatment options, nad debate current treatment paradigms. There is a mini session focusing on the needs of advanced practice providers and pharmacists, as well as a mini-symposium in the management of lung cancer.
Target Audience
Medical Oncologists, Hematologists, Radiation Oncologists, Surgical Oncologists, Pharmacists, Nurse Practitioners, Physician Assistants, Fellows, Nurses, and other health care professionals interested in the treatment of patients with hematologic malignancies
Learning Objectives
- Discuss management strategies for side effect management newly approved treatments in hematologic malignancies
- Discuss advances in molecular diagnostics and the evolution of personalized medicine in lung cancer
- Discuss emerging data and recent advances in the management of hematologic malignancies
- Describe diagnostic strategies for MGUS
- Discuss shared decision making strategies in cancer management
- Describe advances in molecular medicine in lung cancer
- Discuss advances in lung cancer therapies
- Discuss new avenues for the use of stem cell therapy
- Discuss emerging data and recent advances in the treatment of patients with Acute Leukemia, Chronic Leukemia, and Lymphoma
- Discuss treatment strategies for patients with multiple myeloma
- Identify strategies to mitigate cardio-oncologic toxicities
- Identify and manage effects related to immunotherapies such as CAR-T products
Therese Hennig, PA |
Melissa Mackey, PharmD |
Meredith Moorman, PharmD |
Scott Winkel, PA |
Thomas Leblanc, MD |
Ahmed Galal, MD |
Jeffrey Crawford, MD |
Tom Stinchcombe, MD |
Christine Lovly, MD, PhD |
Neal Ready, MD, PhD |
Chris Kelsey, MD |
Jacob Klapper, MD |
David Rizzieri, MD |
Joseph Moore, MD |
Lindsay Rein |
Naveen Pemmaraju, MD |
Carlos DeCastro, MD |
Ara Metjian, MD |
Ewa Wysokinska, MD |
Michael Khouri, MD |
Matthew McKinney |
Steve Shuster, MD |
Richard Lopez, MD |
Danielle Brander, MD |
Kanti Rai, MD |
Cristiana Costa, DO |
Yubin Kang, MD |
Cristina Gasparetto, MD |
Alex Choi, MD |
Louis Diehl, MD |
Linda Sutton, MD |
ACPE
AMA
ANCC
MOC Part 2
JA Credit
Available Credit
- 15.50 ACPE - Pharmacist
- 15.50 AMA PRA Category 1 Credit(s)™
- 15.50 ANCC
- 15.50 Attendance